
Xari S 1000mg/500mg Injection
Marketer
H & Care Incorp
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Xari S 1000mg/500mg Injection
Combiflox 1000mg/500mg Injection, a dual-action antibiotic, combats diverse bacterial infections. Its mechanism prevents microbial proliferation and infection spread. Administration must be solely under a doctor's guidance; strictly adhere to the prescribed schedule. Complete the entire course, even with symptom improvement; premature cessation compromises efficacy. Nausea, vomiting, diarrhea, and dyspepsia are possible side effects; escalating symptoms warrant immediate medical attention. Seek emergency care for allergic reactions (e.g., rash, itching, swelling, dyspnea). Disclose all medications to your physician prior to use. Pregnant or lactating individuals require consultation before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While driving ability is generally unaffected, avoid driving if drowsiness or dizziness occurs. Prioritize rest, a nutritious diet, and ample hydration for optimal recovery. Your physician may order tests to monitor the medication's effects.
Primary Ingredients of Xari S 1000mg/500mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Xari S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Xari S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Xari S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Xari S 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Xari S 1000mg/500mg Injection works:
Xari S Injection, containing 1000mg Ceftriaxone and 500mg Sulbactam, utilizes a dual-action approach to combat bacterial infections. Ceftriaxone, a potent antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The addition of Sulbactam, a beta-lactamase inhibitor, overcomes bacterial resistance mechanisms, thus optimizing Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Xari S 1000mg/500mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Xari S (1000mg/500mg) is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no harm to offspring; nonetheless, clinical data from human studies remain scarce.
Breast feedingCAUTION
Administering Xari S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Xari S 1000mg/500mg Injection can reduce mental acuity, impair visual function, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Xari S 1000mg/500mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Xari S 1000mg/500mg Injection requires careful consideration in individuals with advanced hepatic impairment. Dosage modification of Xari S 1000mg/500mg Injection may be necessary. Medical advice is recommended. Altering the Xari S 1000mg/500mg Injection dosage is not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Xari S 1000mg/500mg Injection :
Should you forget a scheduled dose of Xari S 1000mg/500mg Injection, seek advice from your physician.
Facts to Know About Xari S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
